GlassScriptPhysician profile
Samuel Helman
NPI 1275952756
$3,352.90
in general payments reported to CMS, 2019-2025
18 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $247 · 2021: $72.64 · 2022: $323 · 2023: $667 · 2024: $785 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,585.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,067.39 | 2022-2025 | Inspire |
| Stryker Corporation | $535.61 | 2020-2025 | Na, Scopis Ent, Xpress Ent Dilation System |
| Glaxosmithkline, LLC. | $389.47 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $384.94 | 2023-2025 | Dupixent |
| Optinose US, INC. | $188.88 | 2025 | |
| Medtronic, INC. | $181.95 | 2023-2024 | Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Genzyme Corporation | $138.64 | 2023 | |
| Axogen | $125.25 | 2019 | |
| Davol INC. | $104.85 | 2020 | |
| Merck Sharp & Dohme LLC | $44.33 | 2023-2025 | Keytruda |
| Actelion Pharmaceuticals US, INC. | $32.13 | 2023 | Uptravi, Opsumit |
| Intersect Ent, INC. | $28.58 | 2021 | |
| Aerin Medical INC. | $25.32 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $23.46 | 2025 | Uzedy |
| Abbott Laboratories | $23.27 | 2024 | Freestyle Libre |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.35 | 2024 | |
| Halozyme INC | $19.35 | 2023 | |
| Philips North America LLC | $18.13 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Helman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.